Trial Profile
A Phase I Clinical Trial of Pazopanib in Combination with Escalating Doses of Radioactive 131I in Patients with Well-Differentiated Thyroid Carcinoma Refractory to Radioiodine, Despite Having Some Uptake.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 20 Aug 2023
Price :
$35
*
At a glance
- Drugs Pazopanib (Primary)
- Indications Thyroid cancer
- Focus Adverse reactions; Therapeutic Use
- 01 Sep 2011 New trial record